Delivery Order SPE2DB24D8002-SPE2DB25FJNKB
Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, identified as SPE2DB24D8003 and SPE2DB25FJTJM, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in SAM.gov. The award, valued at $3,304.98, is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products. This contract has an ultimate completion date of November 29, 2024, and is a firm fixed-price delivery order contract. Dakota Drug, Inc. is a key supplier for the DLA...
- This federal contract award, valued at $3,405.30, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of fluticasone-salmeterol 115-21 12GM pharmaceutical products, which are likely used for respiratory conditions. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed-price delivery order. Dakota Drug, Inc. has a significant single-award Indefinite Delivery Contract...
- This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The $6,172.15 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to the DLA. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a wide...
- This federal contract award, valued at $2,698.33, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a performance period ending on March 8, 2024. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support...
- This contract award, valued at $1,524.99, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of February 13, 2025. Dakota Drug, Inc. holds a larger, single-award Indefinite Delivery Contract (IDC) with the DLA, valued at...
- This federal contract award, valued at $4,206.61, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4566601984 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM, a respiratory medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed-price delivery order structure and an ultimate completion date of December 4, 2024....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,437.20 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2024. Dakota Drug, Inc. is an established vendor in the federal medical supply market, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This contract award, identified as SPE2DX15D8002|SPE2DX24F2WN0, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,274.76 firm fixed-price delivery order is for the provision of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product used for respiratory conditions. The award is not associated with a larger contract vehicle, and there is no set-aside designation. Dakota Drug, Inc. is the prime contractor, and there...
- This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJMMW, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,936.85 firm fixed-price delivery order is for the provision of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product used to treat respiratory conditions such as asthma and COPD. Dakota Drug, Inc. has an existing Indefinite Delivery Contract...
- This federal contract award, identified as SPE2DB24D8002|SPE2DB24FJMPU, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Dakota Drug, Inc. The contract is a firm fixed-price delivery order for the delivery of pharmaceutical products, specifically Fluticasone-Salmeterol 115-21 12GM. The total ceiling value of the contract is $1,256.94, and the ultimate completion date is July 18, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged...